Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy.
about
Influence of hepatitis C virus and IL28B genotypes on liver stiffnessStudy of PKRBD in HCV genotype 3a infected patients in response to interferon therapy in Pakistani population.A prognostic model for development of significant liver fibrosis in HIV-hepatitis C co-infectionThe association between interleukin-28B gene polymorphisms as a potential biomarker and the risk of chronic Periodontitis in an Iranian population.Influence of Genetic Polymorphisms of Tumor Necrosis Factor Alpha and Interleukin 10 Genes on the Risk of Liver Cirrhosis in HIV-HCV Coinfected Patients.The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV CoinfectionPredicting Risk of End-Stage Liver Disease in Antiretroviral-Treated Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected PatientsThe Role of Hepatitis C Virus Core Antigen Testing in the Era of Direct Acting Antiviral Therapies: What We Can Learn from the Protease InhibitorsAssociation of IFNL3 and IFNL4 polymorphisms with liver-related mortality in a multiracial cohort of HIV/HCV-coinfected womenBrief Report: Role of Thymic Reconstitution in the Outcome of AIDS-Related PMLLower liver-related death in African-American women with human immunodeficiency virus/hepatitis C virus coinfection, compared to Caucasian and Hispanic women.Interleukin-28 and hepatitis C virus genotype-4: treatment-induced clearance and liver fibrosis.Interleukin-28B rs12979860 C/T Polymorphism and Acute Cellular Rejection after Liver TransplantationGenetics of IL28B and HCV--response to infection and treatment.IL28B polymorphisms as a pretreatment predictor of response to HCV treatment.The role of pharmacogenetics in the treatment of chronic hepatitis C infection.Role of IL28B for chronic hepatitis C treatment toward personalized medicine.APASL consensus statements and management algorithms for hepatitis C virus infection.Host genetic variants influencing the clinical course of hepatitis C virus infection.Distribution of IL28B Polymorphism in a Cohort of Italians and Immigrants with HCV Infection: Association with Viraemia, Stage of Fibrosis and Response to Treatment.Genotype CC of rs12979860 is providing protection against infection rather than assisting in treatment response for HCV genotype 3a infection.Influence of interleukin-28B polymorphism on progression to hepatitis virus-induced hepatocellular carcinoma.Changes in liver fibrosis in HIV/HCV-coinfected patients following different outcomes with peginterferon plus ribavirin therapy.IL28RA polymorphism (rs10903035) is associated with insulin resistance in HIV/HCV-coinfected patients.Effects of the genetic pattern defined by low-density lipoprotein receptor and IL28B genotypes on the outcome of hepatitis C virus infection.A polymorphism linked to RRAS, SCAF1, IRF3 and BCL2L12 genes is associated with cirrhosis in hepatitis C virus carriers.Genetic variation near interleukin 28B and the risk of hepatocellular carcinoma in patients with chronic hepatitis C.Response to pegylated interferon plus ribavirin among HIV/hepatitis C virus-coinfected patients with compensated liver cirrhosis.Host genetic variations associated with disease progression in chronic hepatitis C virus infection.Role of IL-28B genetic variants in HCV-related liver disease severity in patients with different viral genotypes.Genetic polymorphism in cyclooxygenase-2 promoter affects hepatic inflammation and fibrosis in patients with chronic hepatitis C.Epidemiological features of chronic hepatitis C infection caused by remunerated blood donors: A nearly 27-year period survey.AIDS Clinical Research in Spain-Large HIV Population, Geniality of Doctors, and Missing Opportunities.
P2860
Q28542906-0C6DEEC8-C618-49F7-BCF7-9FCD40D4008DQ30356602-D6EA8D59-0BDF-4D2C-ACD7-40A92BB37D00Q33632714-5195EDD7-8E8E-47A7-9931-E014896E07D9Q33837235-00DD8926-A1A2-43E8-B4A4-DE0FB8901077Q34805796-6C4DD122-B414-47A7-AB1F-8128A3B23E24Q35849638-E2D7AA88-346A-4FFF-8913-963F1C9A1DC2Q35952818-9A5E0F09-4B17-49E6-96AF-6A5BD848AF71Q36155389-53260FC6-8337-4B79-A974-2585B898C96BQ36200023-725687B4-1CD0-4228-B3D1-95B173292B21Q36220004-B9D91073-4090-48E0-BA4D-5399826975EEQ36230189-93532E1B-7A58-40DD-B7D7-3A5451D72B7EQ36492644-F9084F69-F91F-4861-BE64-DD7A155D584DQ37695717-858AB6FD-E014-4290-870D-03266E9A69B1Q38013941-A31ED774-B566-4392-915F-102ED60782FCQ38053543-02124F89-0F9C-459F-AFA0-13C7CF15E21EQ38151586-6B8C735F-54E6-4EF2-A81C-992B0EFBE5CAQ38170161-8BE4E951-A5CC-4380-878C-524C57B71FCEQ38552131-E0792D03-2F9F-47A8-991E-C53F8578262FQ38554500-6EAA5F49-2686-4B31-8753-10C29FF93238Q40642039-C79D53FD-A586-4E4E-90BE-3B212524F5E4Q42214593-51D8A6A0-50B2-4478-B559-3C6530386C2CQ42216123-559C57EF-1A8F-4F36-AE0C-517D630D2626Q42218530-AADE19C7-EA13-4538-A3F6-927B8629DB29Q42242609-040F0594-23A0-40F1-9169-26950A54835DQ42261289-56A1D66B-7454-4924-AA26-944F9C822DFDQ42262070-00AFBF69-9423-4F99-92D3-8565C49C5358Q42283445-00462823-7406-40AB-9AC6-D904C3B623E1Q42983977-A7AB2DE2-AFFB-4B43-B0A6-1FC84E3E7E9DQ47566385-3C607768-A0C3-48B7-9CCA-E9146E2B5057Q51735281-41B07977-68C2-40A2-B89E-633B3F3A8C02Q53266646-D8267725-5F26-424B-B687-9B9AF0885AB0Q54250492-3A394F31-FDC4-4733-B240-573F88D9F2C3Q55698444-C6E45320-B278-45D0-806C-3375A5FB9DE6
P2860
Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Influence of interleukin-28B s ...... eiving antiretroviral therapy.
@en
Influence of interleukin-28B s ...... eiving antiretroviral therapy.
@nl
type
label
Influence of interleukin-28B s ...... eiving antiretroviral therapy.
@en
Influence of interleukin-28B s ...... eiving antiretroviral therapy.
@nl
prefLabel
Influence of interleukin-28B s ...... eiving antiretroviral therapy.
@en
Influence of interleukin-28B s ...... eiving antiretroviral therapy.
@nl
P2093
P2860
P50
P921
P356
P1476
Influence of interleukin-28B s ...... ceiving antiretroviral therapy
@en
P2093
Angela Camacho
Eugenia Vispo
John McHutchison
José Medrano
José Miguel Benito
Luz Martín-Carbonero
Pablo Barreiro
Susanna Naggie
P2860
P304
P356
10.1093/INFDIS/JIR113
P407
P577
2011-06-01T00:00:00Z